Cargando…

Prognostic Impact of Non-Cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction following Acute Myocardial Infarction

Background: We aimed to analyze the prevalence and long-term prognostic impact of non-cardiac comorbidities in patients with reduced and preserved left-ventricular ejection fraction (EF) following ST-elevation myocardial infarction (STEMI). Method: A total of 3033 STEMI patients undergoing primary p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savic, Lidija, Mrdovic, Igor, Asanin, Milika, Stankovic, Sanja, Lasica, Ratko, Matic, Dragan, Simic, Damjan, Krljanac, Gordana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381839/ https://www.ncbi.nlm.nih.gov/pubmed/37511723 http://dx.doi.org/10.3390/jpm13071110

Ejemplares similares

Prognostic impact of renal dysfunction on long-term mortality in patients with preserved, moderately impaired, and severely impaired left ventricular systolic function following myocardial infarction
por: Savic, Lidija, et al.
Publicado: (2018)

The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis
por: Savic, Lidija, et al.
Publicado: (2022)

Author`s Reply
por: Savic, Lidija, et al.
Publicado: (2018)

Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary Intervention
por: Savic, Lidija, et al.
Publicado: (2019)

Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
por: Lasica, Ratko, et al.
Publicado: (2022)

Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment
por: Lasica, Ratko, et al.
Publicado: (2023)

Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation
por: Lasica, Ratko, et al.
Publicado: (2022)

Chronic or Changeable Infarct Size after Spontaneous Coronary Artery Dissection
por: Krljanac, Gordana, et al.
Publicado: (2023)

Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism—From Modern Recommendations to Clinical Application
por: Lasica, Ratko, et al.
Publicado: (2022)

Predictors and prognostic implications of hospital-acquired pneumonia in patients admitted for acute heart failure
por: Polovina, Marija, et al.
Publicado: (2023)

The follow-up of myocardial injury and left ventricular function after spontaneous coronary artery dissection
por: Krljanac, Gordana, et al.
Publicado: (2023)

Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke
por: Stankovic, Sanja, et al.
Publicado: (2011)

The Interaction of Apolipoprotein E and Angiotensin I-Converting Enzyme Dna Polymorphisms with Hypertension on Early Ischemic Stroke Risk
por: Stankovic, Sanja, et al.
Publicado: (2010)

Early and Late Mortality Predictors in Patients with Acute Aortic Dissection Type B
por: Lasica, Ratko M., et al.
Publicado: (2022)

Antioxidant Genetic Variants Modify Echocardiography Indices in Long COVID
por: Asanin, Milika, et al.
Publicado: (2023)

Case report: Acute toxic myocardial damage caused by 5-fluorouracil—from enigma to success
por: Lasica, Ratko, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography
por: Bogdanović, Jelena, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction based on aging and comorbidities
por: Lin, Ying, et al.
Publicado: (2021)

A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities
por: Hubesch, Géraldine, et al.
Publicado: (2022)

A network medicine approach to study comorbidities in heart failure with preserved ejection fraction
por: Lanzer, Jan D., et al.
Publicado: (2023)

Rising arterial stiffness with accumulating comorbidities associates with heart failure with preserved ejection fraction
por: Ali, Danish, et al.
Publicado: (2023)

Heart Failure with Preserved Ejection Fraction – Concept, Pathophysiology, Diagnosis and Challenges for Treatment
por: Miljkovik, Lidija Veterovska, et al.
Publicado: (2015)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
por: Edelmann, Frank, et al.
Publicado: (2011)

Novel Göttingen Miniswine Model of Heart Failure With Preserved Ejection Fraction Integrating Multiple Comorbidities
por: Sharp, Thomas E., et al.
Publicado: (2021)

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study
por: Gatzoulis, Konstantinos A, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
por: Antonelli, Lucas, et al.
Publicado: (2015)

Myocardial infarction with a preserved ejection fraction—the impaired function of the cardio-renal baroreflex
por: Pickny, Lisa, et al.
Publicado: (2023)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure
por: Oliveira, Márcia Maria Carneiro, et al.
Publicado: (2018)

SOD2 rs4880 and GPX1 rs1050450 polymorphisms do not confer risk of COVID-19, but influence inflammation or coagulation parameters in Serbian cohort
por: Jerotic, Djurdja, et al.
Publicado: (2022)

GSTO1, GSTO2 and ACE2 Polymorphisms Modify Susceptibility to Developing COVID-19
por: Djukic, Tatjana, et al.
Publicado: (2022)

GSTP1 and GSTM3 Variant Alleles Affect Susceptibility and Severity of COVID-19
por: Coric, Vesna, et al.
Publicado: (2021)

Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID
por: Ercegovac, Marko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_00avmrp1tk8gn2bpliqrqpl2u2